Coronary Chronic Total Occlusion System Market | US | Units Sold, Average Selling Prices, Product Pipeline, Forecasts | 2018-2024| MedCore

  • ID: 4482825
  • Report
  • Region: United States
  • 582 pages
  • iData Research
15 % OFF
until Oct 31st 2018
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Asahi Intecc
  • C.R. Bard
  • Galt Medical
  • Medtronic
  • Teleflex
  • MORE
Crossing a CTO with a guidewire demands surgical skill and patience. With the intention to make CTO crossings easier, faster and less reliant on a physician’s skill, a number of specialized devices have been developed to treat the condition. The procedure is risky, as arterial puncture can occur if the device is pushed out of the lumen, leading to potentially disastrous consequences. As a result, CTO devices have a higher penetration rate in peripheral vascular procedures than coronary ones.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Asahi Intecc
  • C.R. Bard
  • Galt Medical
  • Medtronic
  • Teleflex
  • MORE
Executive Summary
U.S. Interventional Cardiology Device Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History

1. RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecasts and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

2. DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE TREATMENTS AND DIAGNOSTICS
2.2.1 General Diagnostics
2.2.2 Coronary Artery Disease (CAD)
2.2.3 Myocardial Infarction (MI)
2.2.4 Angina Pectoris
2.3 PATIENT DEMOGRAPHICS
2.3.1 General Statistics

3. CORONARY CHRONIC TOTAL OCCLUSION SYSTEM MARKET
3.1 INTRODUCTION
3.2 MARKET OVERVIEW
3.3 MARKET ANALYSIS AND FORECAST
3.3.1 Coronary Chronic Total Occlusion Guidewire Market
3.3.2 Coronary Chronic Total Occlusion Catheter Market
3.3.3 Coronary Chronic Total Occlusion Device Market
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE MARKET SHARE ANALYSIS

Abbreviations
Appendix I: Company Press Releases

List of Charts:
Chart 1 1: Interventional Cardiology Device Market by Segment, U.S., 2014 – 2024
Chart 1 2: Interventional Cardiology Device Market Overview, U.S., 2017 & 2024
Chart 3 1: Coronary Chronic Total Occlusion System Market by Segment, U.S., 2014 – 2024
Chart 3 2: Coronary Chronic Total Occlusion System Market Breakdown by Segment, U.S., 2017
Chart 3 3: Coronary Chronic Total Occlusion System Market Breakdown by Segment, U.S., 2024
Chart 3 4: Coronary Chronic Total Occlusion Guidewire Market, U.S., 2014 – 2024
Chart 3 5: Coronary Chronic Total Occlusion Catheter Market, U.S., 2014 – 2024
Chart 3 6: Coronary Chronic Total Occlusion Device Market, U.S., 2014 – 2024
Chart 3 7: Leading Competitors, Coronary Chronic Total Occlusion System Market, U.S., 2017

List of Figures:
Figure 1 1: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2017 (1 of 3)
Figure 1 2: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2017 (2 of 3)
Figure 1 3: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2017 (3 of 3)
Figure 1 4: Companies Researched in this Report, U.S., 2017
Figure 1 5: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (1 of 3)
Figure 1 6: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (2 of 3)
Figure 1 7: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (3 of 3)
Figure 1 8: Recent Events in the Interventional Cardiology Market, U.S., 2014 – 2017
Figure 1 9: Interventional Cardiology Procedures Covered, U.S., 2017
Figure 1 10: Procedure Codes Investigated, U.S., 2017
Figure 1 11: Interventional Cardiology Markets Covered, U.S., 2017 (1 of 2)
Figure 1 12: Interventional Cardiology Markets Covered, U.S., 2017 (2 of 2)
Figure 1 13: Key Report Updates
Figure 1 14: Version History
Figure 3 1: Coronary Chronic Total Occlusion System Market by Segment, U.S., 2014 – 2024 (US$M)
Figure 3 2: Coronary Chronic Total Occlusion Guidewire Market, U.S., 2014 – 2024
Figure 3 3: Coronary Chronic Total Occlusion Catheter Market, U.S., 2014 – 2024
Figure 3 4: Coronary Chronic Total Occlusion Device Market, U.S., 2014 – 2024
Figure 3 5: Drivers and Limiters, Coronary Chronic Total Occlusion System Market, U.S., 2017
Figure 3 6: Leading Competitors, Coronary Chronic Total Occlusion System Market, U.S., 2017
Figure 5 1: Press Release Summary
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Boston Scientific
  • Abbott Laboratories
  • Medtronic
  • Philips
  • Terumo
  • Cardinal Health
  • Merit Medical Systems
  • Cook Medical
  • Asahi Intecc
  • Teleflex
  • Cardiovascular Systems Inc.
  • Galt Medical
  • C.R. Bard
  • Angiodynamics
  • ACIST Medical Systems
  • Infraredx
  • Tryton Medical
  • B. Braun
  • Maquet
Please Note: Not all companies are currently active in every segment or sub-report from this suite.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll